Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
12 quarters on record
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Jun 30, 2026CallValue
$596,704
CallShares
23,200
PutValue
$596,704
PutShares
23,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in DNLI
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $596,704 | 23,200 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $596,704 | 23,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $433,920 | 22,600 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $433,920 | 22,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $28,067,000 | 1,700,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $36,583,648 | 2,519,535 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $30,973,118 | 2,213,947 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $11,183,300 | 548,739 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,715,728 | 333,530 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,454,143 | 1,053,150 | Shares | Defined | 2024-09-16 | |
| 2023-12-31 | $13,828,952 | 644,406 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $6,594,629 | 223,471 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $1,790,964 | 64,400 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $19,426,770 | 633,000 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||